Evidence map›Paper›PMID 27312561›Full record

ArticleMolecular diagnosis & therapy2016

Impacts of TNF-LTA SNPs/Haplotypes and Lifestyle Factors on Oral Carcinoma in an Indian Population.

Kapil Bandil, Pallavi Singhal, Upma Sharma, Showket Hussain, Surojit Basu, Aditya Parashari, Veena Singh, Ashok Sehgal, Animesh Shivam, Puneet Ahuja and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diagnosis & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kapil BandilDivision of Molecular Genetics and Biochemistry, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, 20130, India.
Pallavi SinghalDivision of Molecular Genetics and Biochemistry, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, 20130, India.
Upma SharmaDivision of Molecular Genetics and Biochemistry, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, 20130, India.
Showket HussainDivision of Molecular Genetics and Biochemistry, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, 20130, India.
Surojit BasuBarasat Cancer Hospital, Kolkata, India.
Aditya ParashariDivision of Molecular Immunology, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, India.
Veena SinghDivision of Clinical Oncology, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, India.
Ashok SehgalDivision of Epidemiology and Biostatistics, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, India.
Animesh ShivamDepartment of Oral Pathology, Institute of Technology and Science, Greater Noida, India.
Puneet AhujaDepartment of Oral Pathology, Institute of Technology and Science, Greater Noida, India.
Mausumi BharadwajDivision of Molecular Genetics and Biochemistry, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, 20130, India. bharadwajm@icmr.org.in.
Basu Dev BanerjeeDepartment of Biochemistry, University College of Medical Sciences, University of Delhi Dilshad Graden, Delhi-65, India.
Ravi MehrotraDivision of Cytopathology, Institute of Cytology and Preventive Oncology (ICMR), I-7, Sector-39, Noida, India.
Institute of Cytology and Preventive Oncology · INUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesTo investigate a potential association between single-nucleotide polymorphisms (SNPs) and  haplotypes at the TNFA-LTA locus and the development of oral cancer in an Indian population. MATERIALS AND

methodsIn this study, 150 oral precancer/cancer samples (50 precancer and 100 cancer), along with an equal number of control samples, were genotyped. Six SNPs at the TNF-LTA locus (i.e., -238G/A, -308G/A, -857C/T, -863C/A, -1031T/C, and +252A/G) were analyzed by use of a polymerase chain reaction-restriction fragment length polymorphism method, the assay was validated by sequencing 10 % of samples.

resultsThe allelic frequencies of TNFA and LTA SNPs were found to be significantly associated with the risk of oral cancer and precancerous lesions in comparison with controls (P < 0.0003). Further haplotypic analysis showed that two haplotypes (ATCTGG and ACACGG) served as risk haplotypes for oral cancer. These haplotypes were also found to be significantly and positively associated with lifestyle habits (tobacco chewing P = 0.04, odds ratio [OR] 3.4) and socioeconomic status (P = 0.01, OR 3.4). We noticed an increased percentage of risk haplotypes correlating with the aggressiveness of oral cancer. The percentages of risk haplotypes were found to be threefold higher in precancer and fourfold higher in advanced stages of oral cancer in comparison with controls.

conclusionFive SNPs at the TNF-LTA locus (i.e., -308G>A, -857C>T, -863C>A, -1031T>C, and +252A>G) were found to be associated with the development of oral cancer. Two haplotypes (ATCTGG and ACACGG) emerged as major risk haplotypes for oral carcinoma progression and were also found to be associated with lifestyle factors and clinical aggressiveness. These findings make the TNF-LTA locus a suitable candidate for a future biomarker, which may be used either for early detection or for helping to improve treatment efficacy and effectiveness.

Indexed as

Life StylePolymorphism, Single NucleotideAdultAllelesCarcinomaCase-Control StudiesDisease ProgressionFemaleGene FrequencyGenotypeHaplotypesHumansIndiaLymphotoxin-alphaMaleMiddle AgedLymphotoxin-alphaTumor Necrosis Factor-alpha

Identifiers

PMID27312561
OpenAlexW2441785770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.